In:
Current Pharmaceutical Design, Bentham Science Publishers Ltd., Vol. 26, No. 34 ( 2020-10-13), p. 4272-4276
Abstract:
Cancer and tumor have been major reasons for numerous deaths in this century across the world. Many
strategies have been designed to treat, diagnose, or prevent cancer. The success of chemotherapy largely depends on drug targeting. The advent of nanotechnology has vastly improved drug delivery for targeting and diagnosis.
Nevertheless, the accuracy of drug targeting with polymeric nanoparticles has always been questionable. The polymeric nanoparticles synthesized from varieties of lipid-based compounds or combined with vectors, such as
liposomes, ethosomes, and transfersomes, may allow the drug to overcome the issue of resistance to drug absorption in biological membranes. The combined effects of lipid-based nanocarriers are known to improve the efficacy
and accuracy of polymeric nanoparticles. The present review explores the application of lipid based nanocarriers in the treatment and diagnosis of cancer A special focus is given to the use of lipid-based nanocarriers in the
treatment, diagnosis, and mitigation of cancer located in blood, brain, lung, and colon. The treatment of these cancers has always been questionable as the chances of relapse are very high. The review encompasses the use of
lipid-based nanocarriers in targeting tissue-specific cancer cells.
Type of Medium:
Online Resource
ISSN:
1381-6128
DOI:
10.2174/1381612826666200720235752
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2020
SSG:
15,3
